LOVENCT05208567
London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 2 years later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Aug 2, 2026 to Aug 2, 2028
- Eligibility criteria expanded, about 2 words
- Study completion pushed from Sep 2, 2026 to Sep 2, 2028
- Collaborators: details revised at 1 of 1 entry
- Notable Primary completion date: Aug 2, 2025 to Aug 2, 2026
- Study completion date: Sep 2, 2025 to Sep 2, 2026
- Notable Primary completion date: Aug 2, 2024 to Aug 2, 2025
- Study completion date: Sep 2, 2024 to Sep 2, 2025
- Notable Primary completion date: Nov 2023 to Aug 2, 2024
- Study completion date: Apr 2024 to Sep 2, 2024
- Minor Start date changed from estimate of Jan 2023 to Mar 14, 2023v3
- Notable Start date: Apr 2022 to Jan 2023v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of participants within a North East London community over the age of 65yrs old with Valvular Heart Disease, as assessed by Cardiac Ultrasound
Timeframe: 12 months
Number of participants within a North East London community over the age of 65yrs old with Left Ventricular Systolic Dysfunction as assessed by Cardiac Ultrasound
Timeframe: 12 months
Diagnostic accuracy in identifying heart valve disease or left ventricular systolic dysfunction using abbreviated echocardiography following training protocols.
Timeframe: 12 months
Arms and interventions
Diagnostic tests: Echocardiogram
Sites
1 site in 1 country
- St Bartholomews HospitalLondon, United Kingdom